| Marc Howard Siegelbaum, MD | |
|
7505 Osler Dr, Ste 506, Towson, MD 21204-7736 | |
| (410) 296-0167 | |
| (410) 296-0099 |
| Full Name | Marc Howard Siegelbaum |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 42 Years |
| Location | 7505 Osler Dr, Towson, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578547287 | NPI | - | NPPES |
| 211501800 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | D0028348 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Md St Joseph Medical Center | Towson, MD | Hospital |
| Greater Baltimore Medical Center | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chesapeake Urology Associates Llc | 4789673393 | 134 |
News Archive
BrainStorm Cell Therapeutics announced today that it has completed the planned interim safety review of its Phase I/II ALS (Amyotrophic Lateral Sclerosis) clinical trial, indicating that autologous transplantation of the Company's cell therapy was well-tolerated, appears to be safe for use, and did not present any undue risks to the study participants.
Covid-19's fierce winter resurgence in California is notable not only for the explosion in overall cases and deaths in the state's sprawling urban centers.
President Donald Trump wants to reopen the country soon. But public health experts from across the ideological spectrum insist that won't be safe until the country can dramatically ramp up testing and contact tracing stemming from those infected.
Research assessing the safety and efficacy of hydroxyurea therapy in pediatric patients with sickle cell disease (SCD) and the use of pre-operative transfusions for patients with SCD who undergo low- and moderate-risk elective surgery will be presented today at the 53rd Annual Meeting of the American Society of Hematology.
› Verified 7 days ago
| Entity Name | Chesapeake Urology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609823004 PECOS PAC ID: 4789673393 Enrollment ID: O20040510000449 |
News Archive
BrainStorm Cell Therapeutics announced today that it has completed the planned interim safety review of its Phase I/II ALS (Amyotrophic Lateral Sclerosis) clinical trial, indicating that autologous transplantation of the Company's cell therapy was well-tolerated, appears to be safe for use, and did not present any undue risks to the study participants.
Covid-19's fierce winter resurgence in California is notable not only for the explosion in overall cases and deaths in the state's sprawling urban centers.
President Donald Trump wants to reopen the country soon. But public health experts from across the ideological spectrum insist that won't be safe until the country can dramatically ramp up testing and contact tracing stemming from those infected.
Research assessing the safety and efficacy of hydroxyurea therapy in pediatric patients with sickle cell disease (SCD) and the use of pre-operative transfusions for patients with SCD who undergo low- and moderate-risk elective surgery will be presented today at the 53rd Annual Meeting of the American Society of Hematology.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marc Howard Siegelbaum, MD 25 Crossroads Dr, Ste 306, Owings Mills, MD 21117-5421 Ph: (410) 296-0167 | Marc Howard Siegelbaum, MD 7505 Osler Dr, Ste 506, Towson, MD 21204-7736 Ph: (410) 296-0167 |
News Archive
BrainStorm Cell Therapeutics announced today that it has completed the planned interim safety review of its Phase I/II ALS (Amyotrophic Lateral Sclerosis) clinical trial, indicating that autologous transplantation of the Company's cell therapy was well-tolerated, appears to be safe for use, and did not present any undue risks to the study participants.
Covid-19's fierce winter resurgence in California is notable not only for the explosion in overall cases and deaths in the state's sprawling urban centers.
President Donald Trump wants to reopen the country soon. But public health experts from across the ideological spectrum insist that won't be safe until the country can dramatically ramp up testing and contact tracing stemming from those infected.
Research assessing the safety and efficacy of hydroxyurea therapy in pediatric patients with sickle cell disease (SCD) and the use of pre-operative transfusions for patients with SCD who undergo low- and moderate-risk elective surgery will be presented today at the 53rd Annual Meeting of the American Society of Hematology.
› Verified 7 days ago
Dr. David S Stampfer, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 7505 Osler Dr, Suite 506, Towson, MD 21204 Phone: 410-296-0167 Fax: 410-296-0099 | |
Jessica Ann Marinaro, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 901 Dulaney Valley Rd Ste 616&100, Towson, MD 21204 Phone: 410-512-8300 Fax: 855-334-8171 | |
Thomas B. Smyth, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 8322 Bellona Ave, Suite 202, Towson, MD 21204 Phone: 410-825-6310 Fax: 410-825-6320 | |
Dr. Joseph Brian Murphy, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 7505 Osler Dr, Suite 508, Towson, MD 21204 Phone: 410-296-5333 Fax: 410-828-7275 | |
Daniel D. Dietrick, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 8322 Bellona Ave, Suite 202, Towson, MD 21204 Phone: 410-825-6310 Fax: 410-825-6320 | |
Stephen M. Busky, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 8322 Bellona Ave, Ste 202, Towson, MD 21204 Phone: 410-825-6310 Fax: 410-825-6320 |